These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 26235542)

  • 1. A new potent analgesic agent with reduced liability to produce morphine tolerance.
    Kiraly K; Caputi FF; Hanuska A; Kató E; Balogh M; Köles L; Palmisano M; Riba P; Hosztafi S; Romualdi P; Candeletti S; Ferdinandy P; Fürst S; Al-Khrasani M
    Brain Res Bull; 2015 Aug; 117():32-8. PubMed ID: 26235542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
    Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.
    Lacko E; Varadi A; Rapavi R; Zador F; Riba P; Benyhe S; Borsodi A; Hosztafi S; Timar J; Noszal B; Furst S; Al-Khrasani M
    Curr Med Chem; 2012; 19(27):4699-707. PubMed ID: 22934777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells.
    Caputi FF; Lattanzio F; Carretta D; Mercatelli D; Candeletti S; Romualdi P
    J Mol Neurosci; 2013 Oct; 51(2):532-8. PubMed ID: 23715695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats.
    Balogh M; Zádori ZS; Lázár B; Karádi D; László S; Mousa SA; Hosztafi S; Zádor F; Riba P; Schäfer M; Fürst S; Al-Khrasani M
    Neurochem Res; 2018 Jun; 43(6):1250-1257. PubMed ID: 29725918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic morphine treatment induces sex- and synapse-specific cellular tolerance on thalamo-cortical mu opioid receptor signaling.
    Jaeckel ER; Arias-Hervert ER; Perez-Medina AL; Schulz S; Birdsong WT
    J Neurophysiol; 2024 Sep; 132(3):968-978. PubMed ID: 39110512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
    Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
    J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
    Tzschentke TM; Rutten K
    Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the Induction of Analgesic Cross-Tolerance Between Opioid and Apelin/APJ Systems in Male Rats.
    Abbasloo E; Esmaeili-Mahani S; Kobeissy F; Currier Thomas T
    J Stud Alcohol Drugs; 2024 Sep; 85(5):704-712. PubMed ID: 38517751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.
    Healy JR; Bezawada P; Shim J; Jones JW; Kane MA; MacKerell AD; Coop A; Matsumoto RR
    ACS Chem Neurosci; 2013 Sep; 4(9):1256-66. PubMed ID: 23713721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats.
    Bie B; Pan ZZ
    Mol Pain; 2005 Feb; 1():7. PubMed ID: 15813995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
    Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
    J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
    Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
    Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats.
    Balogh M; Zádor F; Zádori ZS; Shaqura M; Király K; Mohammadzadeh A; Varga B; Lázár B; Mousa SA; Hosztafi S; Riba P; Benyhe S; Gyires K; Schäfer M; Fürst S; Al-Khrasani M
    Front Pharmacol; 2019; 10():347. PubMed ID: 31024314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation.
    Kumar P; Sunkaraneni S; Sirohi S; Dighe SV; Walker EA; Yoburn BC
    Eur J Pharmacol; 2008 Nov; 597(1-3):39-45. PubMed ID: 18789923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
    Chao PK; Chang HF; Chang WT; Yeh TK; Ou LC; Chuang JY; Tsu-An Hsu J; Tao PL; Loh HH; Shih C; Ueng SH; Yeh SH
    Neuropharmacology; 2020 Apr; 166():107678. PubMed ID: 31278929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.